Gerresheimer stock at EUR 28.90, 9.7 percent below its 52-week high

Published on 10/12/2026 at 13:37 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Gerresheimer stock costs EUR 28.90 on October 12, 2026, versus the EUR 28.66 Xetra close. The high is EUR 32.00 and market value EUR 1.0 billion.

Key points in brief

Gerresheimer stock was at EUR 28.90 at Lang & Schwarz on October 12, 2026, 0.84 percent above the October 9 Xetra close of EUR 28.66.
The price stood 9.69 percent below the 52-week high of EUR 32.00 and the market capitalization was EUR 1.0 billion.
Gerresheimer had a negative P/E of minus 2.49, while SCHOTT Pharma traded at a P/E of 26.54.
Jefferies kept a Hold rating and a EUR 26.80 target on September 30, 2026.

Makroaufnahme der Oberflächenstruktur einer pharmazeutischen Glasampulle — Gerresheimer AG, ISIN DE000A0LD6E6, fertigt hochpräzises Pharmaglas, dessen feine Oberflächenstruktur diese Makroaufnahme eindrucksvoll zeigt, Illustration mit AI erstellt.

Gerresheimer (ISIN DE000A0LD6E6) was trading at EUR 28.90 at Lang & Schwarz on October 12, 2026 at 1:32 p.m. CEST, 0.84 percent above the Xetra close of October 9, 2026 at EUR 28.66. The move places the stock below its yearly peak while keeping the current quotation close to the upper part of its range.

Range leaves room below high

Gerresheimer's 52-week range runs from EUR 14.83 to EUR 32.00 as of October 12, 2026. At EUR 28.90, the stock stood 9.69 percent below the high, while the latest quote was EUR 14.07 above the low.

The company had a market capitalization of EUR 1.0 billion on October 12, 2026. Trading volume stood at 17,060 shares, compared with an average volume of 151,891 shares in the same finance snapshot, making the session's turnover a small fraction of that average.

Comparison with peers

Gerresheimer: plus 0.84 percent, P/E minus 2.49, market capitalization EUR 1.0 billion
SCHOTT Pharma (Frankfurt, EUR): plus 2.77 percent, P/E 26.54, market capitalization EUR 3.6 billion
Stevanato Group (NYSE, USD): plus 0.99 percent, P/E 36.16, market capitalization USD 5.3 billion

Analyst target stays below price

On September 30, 2026, FinanzNachrichten.de reported that Jefferies kept a Hold rating on Gerresheimer and a EUR 26.80 price target. The target was 7.27 percent below the Lang & Schwarz price, using the same euro currency for both figures.

The report also described higher net debt and lower liquidity as balance-sheet concerns. That assessment gives the market price a clear counterpoint: the stock traded above the cited target even as the analyst retained a cautious rating.

Financial calendar points to November

Gerresheimer's investor calendar lists the half-year financial report and the third-quarter statement for November 2026, according to the company's investor-relations page. Those reports are the next scheduled points for updated operating figures after the second-quarter recovery cited in the September analyst assessment.

Price remains below yearly peak

At Lang & Schwarz, Gerresheimer was trading at EUR 28.90 on October 12, 2026 at 1:32 p.m. CEST, 0.84 percent above the Xetra close of EUR 28.66 on October 9, 2026. The further course of trading is shown by the continuously updated real-time quote of Gerresheimer stock.